Quinolone‑Induced Tendon Pain

What is Quinolone‑Induced Tendon Pain?

Quinolone‑induced tendon pain is a musculoskeletal adverse effect that can occur during or shortly after treatment with fluoroquinolone antibiotics (e.g., ciprofloxacin, levofloxacin, moxifloxacin). The condition is thought to result from drug‑related changes in tendon collagen synthesis, oxidative stress, and matrix‑degrading enzymes, leading to inflammation, pain, and in severe cases, tendon rupture. While the reaction can affect any tendon, the Achilles tendon is most commonly involved, followed by the rotator cuff, patellar, and hand‑wrist tendons.

According to the U.S. Food & Drug Administration (FDA), the risk of tendon problems rises with higher doses, prolonged therapy, and in patients who are elderly, on corticosteroids, or have pre‑existing tendon disease. Most cases are reversible, but prompt recognition is essential to avoid permanent damage.

Common Causes

Quinolone‑induced tendon pain is not caused by a single factor; it results from the interaction of several risk elements. The following are the most frequent contributors:

• Fluoroquinolone antibiotics: ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, gemifloxacin.
• High‑dose or prolonged therapy: treatment courses >14 days or doses exceeding recommended limits.
• Elderly age (≥60 years): tendons naturally become less elastic with age.
• Concurrent corticosteroid use: systemic steroids amplify collagen breakdown.
• Renal impairment: reduced clearance leads to higher drug exposure.
• Physical stress on tendons: recent vigorous exercise, running, or manual labor.
• Pre‑existing tendon disease or previous tendon injury.
• Diabetes mellitus: microvascular changes affect tendon health.
• Hyperthyroidism or hypothyroidism: metabolic disturbances influence connective tissue.
• Smoking: impairs collagen synthesis and blood flow.

Associated Symptoms

When a fluoroquinolone irritates a tendon, patients often notice a cluster of symptoms that together suggest tendon involvement:

• Gradual or sudden onset of deep, aching pain localized to the tendon (most often the Achilles, shoulder, or knee).
• Swelling or localized warmth over the affected area.
• Stiffness, especially in the morning or after periods of inactivity.
• Crepitating sensation (“grating”) when the tendon moves.
• Reduced range of motion or weakness in the muscle that the tendon serves.
• Occasional bruising if a micro‑tear has begun.
• In severe cases, a palpable “gap” or sudden loss of function indicating a rupture.

When to See a Doctor

Because tendon damage can progress quickly, it is important to seek medical care promptly if you experience any of the following while taking a fluoroquinolone or within a few weeks after stopping it:

• New or worsening tendon pain that does not improve with rest.
• Swelling, warmth, or redness over a tendon.
• Sudden “pop” sensation or the feeling that the tendon has “snapped”.
• Difficulty bearing weight on a leg or using the arm associated with the painful tendon.
• Persistent pain that interferes with daily activities (walking, climbing stairs, lifting objects).
• Any sign of infection (fever, chills) combined with tendon pain.

Early evaluation can prevent rupture and allow a quicker return to normal function.

Diagnosis

Diagnosis is primarily clinical, but physicians may use imaging and laboratory tests to confirm and rule out other conditions.

Clinical evaluation

• History: timing of symptom onset relative to fluoroquinolone use, dosage, and presence of risk factors.
• Physical examination: inspection for swelling, palpation for tenderness, assessment of tendon integrity (Thompson test for Achilles, drop arm test for rotator cuff).

Imaging studies

• Ultrasound: quick, bedside tool to detect tendon thickening, partial tears, or fluid collections.
• MRI: gold‑standard for detailed evaluation of tendon structure, especially when rupture is suspected.

Laboratory tests (optional)

• Complete blood count (CBC) and C‑reactive protein (CRP) to assess for systemic inflammation.
• Serum drug levels are rarely measured but may be considered in patients with renal failure.

Treatment Options

Treatment focuses on removing the offending drug, relieving pain, supporting tendon healing, and preventing rupture.

Immediate steps

• Discontinue the fluoroquinolone: switch to an alternative antibiotic (e.g., doxycycline, azithromycin) after consulting the prescribing clinician.
• Immobilization: use a brace, splint, or walking boot to limit stress on the affected tendon.
• Ice application: 15‑20 minutes every 2–3 hours for the first 48‑72 hours to reduce swelling.
• Analgesia: acetaminophen or short‑course NSAIDs (if no contraindication) for pain control.

Medical management

• Physical therapy: after the acute phase, guided stretching and eccentric strengthening improve collagen remodeling.
• Collagen‑supporting supplements: vitamin C (500 mg daily) and gelatin or hydrolyzed collagen have some evidence for enhancing tendon repair (source: J Orthop Sports Phys Ther, 2019).
• Platelet‑rich plasma (PRP) or autologous growth factors: considered in persistent cases; data are still emerging.

Surgical intervention

If imaging confirms a complete rupture or if functional loss persists despite conservative care, surgical repair may be required. Post‑operative rehabilitation is essential for regaining strength.

Prevention Tips

Because the risk is linked to both drug exposure and patient factors, the following strategies can lower the chance of tendon pain:

• Reserve fluoroquinolones for cases where no safer alternative exists: follow antimicrobial stewardship guidelines (CDC, 2023).
• Use the shortest effective course and lowest effective dose.
• Avoid concurrent systemic steroids unless absolutely necessary; if they must be used, monitor tendon health closely.
• Assess renal function before prescribing: dose‑adjust in patients with creatinine clearance <60 mL/min.
• Educate patients about early warning signs: provide written information on what to watch for.
• Encourage gentle activity, not high‑impact exercise, during treatment.
• Control chronic diseases (diabetes, thyroid disorders) and encourage smoking cessation.
• Consider prophylactic use of calcium and vitamin D: maintaining bone‑tendon health may be beneficial, especially in older adults.

Emergency Warning Signs

Key Take‑aways

Quinolone‑induced tendon pain is a preventable, drug‑related condition that can progress to serious injury if not recognized early. Discontinuing the fluoroquinolone, limiting tendon stress, and obtaining prompt medical evaluation are the cornerstones of care. Patients and clinicians should stay alert to risk factors and educate themselves on early symptoms. When in doubt, err on the side of caution and contact a healthcare professional.

---

References:

• Mayo Clinic. Fluoroquinolone antibiotics: Side effects and risks. 2023.
• U.S. Food & Drug Administration. FDA Safety Alert: Fluoroquinolone-Associated Tendonitis and Tendon Rupture. 2022.
• Cleveland Clinic. Fluoroquinolone-induced Tendon Damage. 2024.
• Centers for Disease Control and Prevention. Antimicrobial Stewardship Guidance. 2023.
• National Institutes of Health. Collagen supplementation and tendon healing. 2021.
• World Health Organization. Guidelines for the Use of Antimicrobials. 2022.